Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epithelial Sodium Channels | 12 | 2016 | 31 | 2.700 |
Why?
|
Sodium | 8 | 2014 | 352 | 1.550 |
Why?
|
Epithelial-Mesenchymal Transition | 8 | 2023 | 973 | 1.240 |
Why?
|
Immediate-Early Proteins | 6 | 2012 | 107 | 1.080 |
Why?
|
Lung | 6 | 2022 | 3167 | 1.030 |
Why?
|
Phospholipid Transfer Proteins | 3 | 2022 | 25 | 0.950 |
Why?
|
Adenosine Deaminase | 2 | 2022 | 94 | 0.950 |
Why?
|
Pulmonary Fibrosis | 2 | 2022 | 172 | 0.890 |
Why?
|
Mentoring | 1 | 2024 | 87 | 0.850 |
Why?
|
Connective Tissue Growth Factor | 1 | 2022 | 43 | 0.820 |
Why?
|
Adenosine Triphosphatases | 3 | 2022 | 435 | 0.780 |
Why?
|
Aldosterone | 5 | 2012 | 73 | 0.770 |
Why?
|
Membrane Proteins | 4 | 2014 | 2811 | 0.650 |
Why?
|
Trophoblasts | 7 | 2006 | 138 | 0.640 |
Why?
|
RNA-Binding Proteins | 2 | 2022 | 984 | 0.630 |
Why?
|
Biomedical Research | 1 | 2024 | 807 | 0.570 |
Why?
|
Neoplastic Stem Cells | 4 | 2023 | 1439 | 0.510 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 2 | 2012 | 61 | 0.510 |
Why?
|
Signal Transduction | 9 | 2022 | 11972 | 0.510 |
Why?
|
Serine Proteases | 1 | 2014 | 19 | 0.500 |
Why?
|
Epithelial Cells | 8 | 2023 | 1818 | 0.460 |
Why?
|
Vision, Ocular | 1 | 2014 | 157 | 0.460 |
Why?
|
Transcription Factors | 8 | 2017 | 5253 | 0.450 |
Why?
|
Eye Proteins | 1 | 2014 | 268 | 0.440 |
Why?
|
Multiprotein Complexes | 2 | 2012 | 389 | 0.440 |
Why?
|
Acute Lung Injury | 4 | 2019 | 92 | 0.440 |
Why?
|
Kidney Tubules, Collecting | 2 | 2014 | 27 | 0.430 |
Why?
|
Hyperoxia | 4 | 2019 | 134 | 0.430 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2012 | 853 | 0.410 |
Why?
|
Proteogenomics | 2 | 2024 | 88 | 0.410 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2018 | 716 | 0.410 |
Why?
|
Aging | 2 | 2019 | 1533 | 0.410 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 696 | 0.400 |
Why?
|
Retina | 1 | 2014 | 532 | 0.380 |
Why?
|
RNA | 1 | 2015 | 1010 | 0.370 |
Why?
|
Nephrons | 1 | 2010 | 48 | 0.370 |
Why?
|
Oxygen | 3 | 2019 | 755 | 0.360 |
Why?
|
Lung Diseases | 1 | 2015 | 721 | 0.360 |
Why?
|
Phenanthrenes | 1 | 2009 | 42 | 0.350 |
Why?
|
Ubiquitination | 2 | 2021 | 579 | 0.350 |
Why?
|
Animals | 30 | 2022 | 59489 | 0.340 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2009 | 98 | 0.340 |
Why?
|
Diterpenes | 1 | 2009 | 112 | 0.340 |
Why?
|
ADAM Proteins | 1 | 2009 | 133 | 0.330 |
Why?
|
Endoplasmic Reticulum | 1 | 2010 | 310 | 0.330 |
Why?
|
Alveolar Epithelial Cells | 3 | 2018 | 48 | 0.330 |
Why?
|
Transcriptome | 4 | 2020 | 1863 | 0.320 |
Why?
|
Sodium Channels | 2 | 2006 | 109 | 0.320 |
Why?
|
Protease Inhibitors | 1 | 2009 | 210 | 0.320 |
Why?
|
Up-Regulation | 1 | 2014 | 2450 | 0.320 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2007 | 15 | 0.310 |
Why?
|
Quercetin | 1 | 2007 | 16 | 0.310 |
Why?
|
Cell Differentiation | 8 | 2015 | 4043 | 0.310 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2022 | 168 | 0.300 |
Why?
|
DNA | 1 | 2015 | 2683 | 0.300 |
Why?
|
Mitochondria | 3 | 2019 | 1281 | 0.280 |
Why?
|
Intermediate Filaments | 2 | 2023 | 27 | 0.270 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 591 | 0.270 |
Why?
|
Oxidative Stress | 4 | 2019 | 1129 | 0.270 |
Why?
|
Mice | 15 | 2022 | 34393 | 0.270 |
Why?
|
Lipid Metabolism | 1 | 2007 | 481 | 0.240 |
Why?
|
Humans | 44 | 2024 | 262248 | 0.230 |
Why?
|
Breast Neoplasms | 5 | 2021 | 15709 | 0.230 |
Why?
|
MicroRNAs | 2 | 2021 | 2955 | 0.220 |
Why?
|
Faculty | 1 | 2024 | 133 | 0.220 |
Why?
|
Telomerase | 4 | 2009 | 524 | 0.210 |
Why?
|
Uteroglobin | 2 | 2019 | 53 | 0.210 |
Why?
|
Cell Movement | 4 | 2019 | 2462 | 0.210 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 32 | 0.210 |
Why?
|
Career Choice | 1 | 2024 | 234 | 0.200 |
Why?
|
Neuroblastoma | 1 | 2007 | 683 | 0.200 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2004 | 166 | 0.200 |
Why?
|
Mentors | 1 | 2024 | 203 | 0.200 |
Why?
|
Glucocorticoids | 1 | 2005 | 637 | 0.200 |
Why?
|
Mice, Inbred C57BL | 7 | 2022 | 6927 | 0.200 |
Why?
|
Placenta | 5 | 2006 | 519 | 0.200 |
Why?
|
Cell Line | 6 | 2021 | 5071 | 0.200 |
Why?
|
Vimentin | 2 | 2023 | 252 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 5778 | 0.190 |
Why?
|
Platelet Factor 4 | 1 | 2021 | 36 | 0.190 |
Why?
|
Nedd4 Ubiquitin Protein Ligases | 2 | 2012 | 23 | 0.190 |
Why?
|
Infertility, Male | 2 | 2015 | 296 | 0.190 |
Why?
|
CD8 Antigens | 1 | 2021 | 170 | 0.190 |
Why?
|
CD4 Antigens | 1 | 2021 | 170 | 0.190 |
Why?
|
Hypertension | 1 | 2010 | 1514 | 0.190 |
Why?
|
Bleomycin | 1 | 2022 | 467 | 0.190 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 2504 | 0.180 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 5155 | 0.180 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2015 | 1485 | 0.180 |
Why?
|
Cell Line, Tumor | 8 | 2023 | 14561 | 0.180 |
Why?
|
HEK293 Cells | 3 | 2019 | 1498 | 0.180 |
Why?
|
Benzodioxoles | 1 | 2019 | 29 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2019 | 7241 | 0.170 |
Why?
|
Choriocarcinoma | 1 | 2009 | 47 | 0.170 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1667 | 0.170 |
Why?
|
Biological Transport | 3 | 2011 | 598 | 0.170 |
Why?
|
Transfection | 2 | 2009 | 2934 | 0.160 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2019 | 163 | 0.160 |
Why?
|
RNA, Messenger | 6 | 2022 | 6129 | 0.160 |
Why?
|
Curriculum | 1 | 2024 | 868 | 0.160 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3233 | 0.160 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 25 | 0.160 |
Why?
|
Interleukin-1beta | 2 | 2016 | 301 | 0.150 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 474 | 0.150 |
Why?
|
Cell Transdifferentiation | 1 | 2018 | 111 | 0.150 |
Why?
|
Databases, Genetic | 1 | 2020 | 746 | 0.150 |
Why?
|
ADAMTS Proteins | 1 | 2016 | 14 | 0.150 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2016 | 25 | 0.140 |
Why?
|
Claudins | 1 | 2016 | 47 | 0.140 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 678 | 0.140 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2016 | 19 | 0.140 |
Why?
|
Forkhead Transcription Factors | 3 | 2017 | 777 | 0.140 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2016 | 7 | 0.140 |
Why?
|
Leydig Cells | 1 | 2006 | 39 | 0.140 |
Why?
|
Guanosine | 1 | 2015 | 22 | 0.140 |
Why?
|
Aldehydes | 1 | 2015 | 44 | 0.140 |
Why?
|
Phosphorylation | 5 | 2023 | 4809 | 0.140 |
Why?
|
Oxidants | 1 | 2015 | 49 | 0.130 |
Why?
|
Transforming Growth Factor beta | 5 | 2006 | 1109 | 0.130 |
Why?
|
Alu Elements | 1 | 2015 | 87 | 0.130 |
Why?
|
Mouse Embryonic Stem Cells | 1 | 2015 | 48 | 0.130 |
Why?
|
RNA Editing | 1 | 2015 | 92 | 0.130 |
Why?
|
Mitosis | 1 | 2017 | 612 | 0.130 |
Why?
|
Cell Membrane | 2 | 2009 | 855 | 0.120 |
Why?
|
Microphthalmos | 1 | 2014 | 57 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2007 | 460 | 0.120 |
Why?
|
3' Untranslated Regions | 1 | 2015 | 345 | 0.120 |
Why?
|
Protein Isoforms | 3 | 2019 | 836 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2021 | 293 | 0.120 |
Why?
|
Water-Electrolyte Balance | 1 | 2014 | 104 | 0.120 |
Why?
|
Retinitis Pigmentosa | 1 | 2014 | 79 | 0.120 |
Why?
|
Inflammasomes | 1 | 2016 | 162 | 0.120 |
Why?
|
Actins | 1 | 2016 | 605 | 0.120 |
Why?
|
Benzamides | 1 | 2019 | 1834 | 0.120 |
Why?
|
Neoplasms | 4 | 2024 | 15180 | 0.110 |
Why?
|
Placentation | 1 | 2003 | 60 | 0.110 |
Why?
|
Spermatogenesis | 1 | 2015 | 308 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 1596 | 0.110 |
Why?
|
Mice, Mutant Strains | 1 | 2014 | 623 | 0.110 |
Why?
|
Endothelial Cells | 1 | 2019 | 1046 | 0.110 |
Why?
|
PDZ Domains | 1 | 2012 | 20 | 0.110 |
Why?
|
Ion Transport | 2 | 2014 | 79 | 0.110 |
Why?
|
Adenine | 1 | 2015 | 639 | 0.110 |
Why?
|
Lipid Peroxidation | 2 | 2016 | 154 | 0.110 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2012 | 32 | 0.110 |
Why?
|
Trans-Activators | 1 | 2019 | 1557 | 0.100 |
Why?
|
Cell Cycle Proteins | 2 | 2016 | 2053 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2582 | 0.100 |
Why?
|
Membrane Microdomains | 1 | 2012 | 81 | 0.100 |
Why?
|
Estrogens | 1 | 2006 | 749 | 0.100 |
Why?
|
Models, Biological | 2 | 2011 | 3242 | 0.100 |
Why?
|
Blotting, Western | 4 | 2009 | 3529 | 0.100 |
Why?
|
Mice, Transgenic | 2 | 2016 | 4126 | 0.100 |
Why?
|
DNA, Complementary | 3 | 2005 | 870 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8882 | 0.100 |
Why?
|
Receptors, LHRH | 1 | 2001 | 41 | 0.100 |
Why?
|
Female | 16 | 2022 | 142293 | 0.090 |
Why?
|
Estradiol | 1 | 2004 | 746 | 0.090 |
Why?
|
Neoplasm Metastasis | 2 | 2023 | 5124 | 0.090 |
Why?
|
ADAM10 Protein | 1 | 2009 | 12 | 0.090 |
Why?
|
Cell Cycle | 1 | 2016 | 2085 | 0.090 |
Why?
|
Fetus | 1 | 2003 | 592 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6223 | 0.090 |
Why?
|
Epoxy Compounds | 1 | 2009 | 55 | 0.090 |
Why?
|
Chromatography, Affinity | 1 | 2009 | 120 | 0.090 |
Why?
|
U937 Cells | 1 | 2009 | 172 | 0.090 |
Why?
|
Cell Division | 3 | 2004 | 2467 | 0.090 |
Why?
|
Biotinylation | 1 | 2009 | 47 | 0.090 |
Why?
|
Cell Growth Processes | 1 | 2009 | 342 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2009 | 81 | 0.080 |
Why?
|
Computational Biology | 1 | 2015 | 1270 | 0.080 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2019 | 1215 | 0.080 |
Why?
|
Disease Models, Animal | 1 | 2022 | 7218 | 0.080 |
Why?
|
Embryo Implantation | 1 | 2001 | 276 | 0.080 |
Why?
|
Organ Specificity | 2 | 2007 | 695 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2021 | 11571 | 0.080 |
Why?
|
Xenopus laevis | 2 | 2007 | 268 | 0.080 |
Why?
|
Binding Sites | 2 | 2009 | 2170 | 0.080 |
Why?
|
Protein Transport | 1 | 2010 | 734 | 0.080 |
Why?
|
Hemiterpenes | 1 | 2007 | 6 | 0.080 |
Why?
|
Intramolecular Transferases | 1 | 2007 | 5 | 0.080 |
Why?
|
Ion Channels | 1 | 2009 | 212 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2003 | 1151 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 3632 | 0.080 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2007 | 43 | 0.080 |
Why?
|
Organophosphorus Compounds | 1 | 2007 | 102 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2015 | 3127 | 0.080 |
Why?
|
Rats | 3 | 2007 | 6107 | 0.070 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 4027 | 0.070 |
Why?
|
Pregnancy | 6 | 2004 | 7549 | 0.070 |
Why?
|
Homeostasis | 1 | 2012 | 941 | 0.070 |
Why?
|
Sarcoma | 1 | 2017 | 1725 | 0.070 |
Why?
|
Phosphatidylinositols | 1 | 2007 | 60 | 0.070 |
Why?
|
Male | 9 | 2022 | 123338 | 0.070 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 216 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 2485 | 0.070 |
Why?
|
United States | 1 | 2024 | 15574 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 2288 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2016 | 5598 | 0.070 |
Why?
|
Leucine Zippers | 1 | 2005 | 38 | 0.070 |
Why?
|
Butadienes | 1 | 2005 | 35 | 0.070 |
Why?
|
Ions | 1 | 2005 | 54 | 0.070 |
Why?
|
Gene Expression | 2 | 2019 | 3563 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 5435 | 0.060 |
Why?
|
Xenopus | 1 | 2005 | 220 | 0.060 |
Why?
|
Electrophysiology | 1 | 2005 | 333 | 0.060 |
Why?
|
Cholesterol | 1 | 2007 | 656 | 0.060 |
Why?
|
Blood Pressure | 1 | 2010 | 1466 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2005 | 591 | 0.060 |
Why?
|
Macaca mulatta | 3 | 2019 | 717 | 0.060 |
Why?
|
Epididymis | 1 | 2003 | 68 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 4768 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 4231 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 10021 | 0.060 |
Why?
|
Progesterone | 1 | 2005 | 509 | 0.060 |
Why?
|
Oocytes | 1 | 2005 | 412 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 766 | 0.050 |
Why?
|
Seminal Plasma Proteins | 1 | 2002 | 8 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 4787 | 0.050 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 93 | 0.050 |
Why?
|
Tumor Escape | 1 | 2024 | 253 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2005 | 1760 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 2215 | 0.050 |
Why?
|
Transplantation, Isogeneic | 1 | 2021 | 59 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 104 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 53 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2022 | 255 | 0.050 |
Why?
|
Apoptosis | 2 | 2009 | 7601 | 0.050 |
Why?
|
Nitriles | 1 | 2005 | 904 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2021 | 129 | 0.050 |
Why?
|
Stem Cells | 2 | 2019 | 1206 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 198 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 15167 | 0.050 |
Why?
|
Cyclin A2 | 2 | 2004 | 5 | 0.050 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2021 | 101 | 0.050 |
Why?
|
Down-Regulation | 1 | 2005 | 2078 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 277 | 0.050 |
Why?
|
Acetylation | 1 | 2021 | 511 | 0.040 |
Why?
|
Cyclin A | 2 | 2004 | 45 | 0.040 |
Why?
|
Testis | 2 | 2015 | 716 | 0.040 |
Why?
|
Base Sequence | 3 | 2009 | 4886 | 0.040 |
Why?
|
Aldehyde Dehydrogenase, Mitochondrial | 1 | 2019 | 3 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 847 | 0.040 |
Why?
|
Lithium Chloride | 1 | 2019 | 28 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 3189 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2004 | 523 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2021 | 1054 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 904 | 0.040 |
Why?
|
Spermatozoa | 2 | 2015 | 311 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 2019 | 290 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 9195 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 181 | 0.040 |
Why?
|
Microvessels | 1 | 2019 | 136 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 1879 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2019 | 210 | 0.040 |
Why?
|
Cyclin E | 2 | 2004 | 266 | 0.040 |
Why?
|
Time Factors | 2 | 2015 | 12984 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2018 | 5672 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 566 | 0.040 |
Why?
|
DNA Primers | 1 | 2009 | 1395 | 0.040 |
Why?
|
Kidney | 1 | 2005 | 2144 | 0.040 |
Why?
|
Proteomics | 1 | 2024 | 1386 | 0.040 |
Why?
|
Cell Death | 1 | 2019 | 672 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 608 | 0.030 |
Why?
|
Polyribosomes | 1 | 2015 | 34 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2019 | 428 | 0.030 |
Why?
|
Aconitate Hydratase | 1 | 2015 | 20 | 0.030 |
Why?
|
Caspase 1 | 1 | 2016 | 64 | 0.030 |
Why?
|
Internet | 1 | 2020 | 715 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3983 | 0.030 |
Why?
|
Thioredoxins | 1 | 2015 | 50 | 0.030 |
Why?
|
Protective Factors | 1 | 2016 | 107 | 0.030 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 110 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2015 | 131 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2009 | 5378 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2003 | 2022 | 0.030 |
Why?
|
Drug Discovery | 1 | 2017 | 326 | 0.030 |
Why?
|
Pyrroles | 1 | 2019 | 584 | 0.030 |
Why?
|
Aquaporin 2 | 1 | 2014 | 6 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2018 | 874 | 0.030 |
Why?
|
Protein Binding | 1 | 2021 | 3438 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 469 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2016 | 425 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2014 | 42 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2015 | 398 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 626 | 0.030 |
Why?
|
Placental Hormones | 1 | 2003 | 2 | 0.030 |
Why?
|
Body Water | 1 | 2014 | 132 | 0.030 |
Why?
|
Glycodelin | 1 | 2003 | 1 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2015 | 33028 | 0.030 |
Why?
|
Hormone Antagonists | 1 | 2004 | 101 | 0.030 |
Why?
|
Cytokines | 2 | 2012 | 2824 | 0.030 |
Why?
|
Pregnancy Proteins | 1 | 2003 | 44 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 132 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 573 | 0.030 |
Why?
|
Germ Cells | 1 | 2015 | 338 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 4303 | 0.030 |
Why?
|
Potassium | 1 | 2014 | 330 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1077 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2003 | 127 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 6062 | 0.030 |
Why?
|
Genomics | 1 | 2024 | 2744 | 0.030 |
Why?
|
Gene Deletion | 1 | 2018 | 1440 | 0.030 |
Why?
|
Heterozygote | 1 | 2015 | 1015 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3818 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 5009 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8885 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2012 | 166 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2012 | 84 | 0.030 |
Why?
|
Adipogenesis | 1 | 2012 | 106 | 0.020 |
Why?
|
Blotting, Northern | 2 | 2002 | 672 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 507 | 0.020 |
Why?
|
Thymus Gland | 1 | 2012 | 294 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2003 | 488 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2001 | 150 | 0.020 |
Why?
|
Immune System | 1 | 2012 | 282 | 0.020 |
Why?
|
Spleen | 1 | 2012 | 674 | 0.020 |
Why?
|
Glycoproteins | 1 | 2003 | 746 | 0.020 |
Why?
|
Genetic Loci | 1 | 2012 | 482 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 559 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2015 | 994 | 0.020 |
Why?
|
Endometrium | 1 | 2003 | 469 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 3042 | 0.020 |
Why?
|
Uterus | 1 | 2003 | 673 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 1070 | 0.020 |
Why?
|
Oligopeptides | 1 | 2001 | 425 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2012 | 653 | 0.020 |
Why?
|
Models, Molecular | 2 | 2003 | 1740 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1026 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 4945 | 0.020 |
Why?
|
Isomerism | 1 | 2007 | 63 | 0.020 |
Why?
|
Body Weight | 1 | 2012 | 1292 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2003 | 2915 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2003 | 7545 | 0.020 |
Why?
|
Dexamethasone | 1 | 2012 | 1450 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2007 | 102 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2007 | 199 | 0.020 |
Why?
|
Catalysis | 1 | 2007 | 249 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2004 | 2085 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3538 | 0.020 |
Why?
|
Macrophages | 1 | 2012 | 1313 | 0.020 |
Why?
|
Fibroblasts | 1 | 2012 | 1642 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2007 | 397 | 0.020 |
Why?
|
Point Mutation | 1 | 2007 | 769 | 0.010 |
Why?
|
Lipocalins | 1 | 2003 | 54 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2003 | 72 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 21737 | 0.010 |
Why?
|
Cystatins | 1 | 2002 | 15 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2003 | 290 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 521 | 0.010 |
Why?
|
Colforsin | 1 | 2001 | 59 | 0.010 |
Why?
|
Cyclins | 1 | 2003 | 448 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 29996 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 1208 | 0.010 |
Why?
|
Giant Cells | 1 | 2001 | 67 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 475 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2007 | 1684 | 0.010 |
Why?
|
Androgens | 1 | 2002 | 514 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2002 | 996 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2003 | 809 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 1476 | 0.010 |
Why?
|
Escherichia coli | 1 | 2002 | 1207 | 0.010 |
Why?
|
Aged | 1 | 2021 | 70367 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2003 | 1826 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2002 | 3076 | 0.010 |
Why?
|
Adult | 1 | 2021 | 78179 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 86544 | 0.010 |
Why?
|